Navigation Links
Mentice AB Announces Leadership Changes Within Its Worldwide Operations
Date:3/11/2008

GOTHENBURG, Sweden, March 11 /PRNewswire/ -- Mentice AB, a leading supplier of virtual reality based training applications within the field of medicine has recently appointed James Ruscoe as Chairman of the Board and Goran Malmberg as President and CEO of Mentice.

Mr. Ruscoe graduated from Oxford University and brings with him a vast array of experience in innovative technologies. He also serves as CEO and board member of several Swiss private and charitable foundations. Mr. Ruscoe is the former advisor to the Presidency of the European Commission on the competitive implications of innovation; to the Chairman of the European Round Table of Industrialists, Brussels; and to the Chairman of the Italian National Agency for Innovation, New Technologies and the Environment, Rome.

Mr. Malmberg, formerly a member of the Mentice board, has extensive sales and marketing experience from executive positions within the software industry and has held sales management and senior executive roles with international focus during the last 15 years.

"I am excited about joining Mentice which I personally feel is an innovative and progressive company in a market with considerable potential. My goal is to develop the company through further product development while enhancing our sales and marketing operations. We trust the industry will notice the result of these changes in the very near future as Mentice works to maintain its leadership position by broadening its presence throughout the worldwide VR marketplace," said Goran Malmberg.

About Mentice:

Mentice is a leader in medical simulation with approximately 600 installations worldwide, 100 validation studies and more than 30 issued and pending patents. Mentice's Family of Procedicus (TM) simulators focus on the area of minimally invasive surgery within the fields of endovascular, cardiovascular and neurological intervention, core skills training, laparoscopy and arthroscopy.

Website info: http://www.mentice.com

Release #31008


'/>"/>
SOURCE Mentice Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
2. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
3. Lilly Announces Termination of AIR Insulin Program
4. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
5. Spectral announces 2007 financial results
6. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
7. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
8. Senetek PLC Announces Appointments of Key Personnel
9. Iomai Announces Year-End 2007 Financial Results and Business Progress
10. Dragon announces new product launch; increase in annual production output capacity
11. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... MacArthur Sotheby’s International Realty, ... pleased to announce the first Delos Wellness Signature™ residence in Hawaii is on ... working together with listing agent Kelly Allen, R(S) of Carvill Sotheby’s International Realty ...
(Date:8/21/2017)... ... 2017 , ... Boston Strategic Partners, Inc. (BSP), a life-sciences ... Outcomes Research (HEOR) and ‘big data’ to provide a variety of in-depth analysis ... trillion with nearly 1/3 spent on hospitalizations. BSP has access to real-world data ...
(Date:8/18/2017)... ... August 18, 2017 , ... Producers of the award winning ... in an upcoming episode, scheduled to broadcast fourth quarter 2017. American Farmer airs ... the independent, family-owned seed company. Educating audiences about its broad portfolio of products ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... personalized medicine, today announced the launch of a new breast cancer monitoring study ... goal is to evaluate the potential for early detection of recurrent breast cancer ...
Breaking Biology Technology:
(Date:8/15/2017)...   ivWatch LLC , a medical device company focused on ... receipt of its ISO 13485 Certification, the global standard for medical ... Standardization (ISO®). ... Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as ...
(Date:7/20/2017)... WASHINGTON , July 20, 2017 Delta (NYSE: ... to board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics ... Delta,s ... Delta Sky Club is now integrated into the boarding process to ...
(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
Breaking Biology News(10 mins):